Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...
Amazon will now help its customers lose weight. The company will be providing GLP-1 treatments for weight loss through its ...
West Pharmaceutical Services Inc. is set to report first-quarter earnings Thursday before the market opens, with investors scrutinizing whether the injectable packaging supplier c ...
Outspoken body acceptance advocate Katie Sturino, who is the founder of Megababe Beauty, explains why it was a difficult ...
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences ...
Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...
The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 December 2027.
Alcohol intake rates frequently fall after traumatic events, such as the AIDS epidemic in 1981 and now after the COVID-19 ...
Cardiovascular care is transitioning from primarily managing acute conditions to focusing on prevention and interventions for ...
Investor's Business Daily on MSN
Obesity drugs covered in Medicare change. Questions remain for Lilly, Novo.
CMS flipped its stance late Tuesday, saying it will cover the cost of obesity drugs beginning July 1 through the end of 2027.
Researchers evaluated potential associations between semaglutide exposure and ischemic optic neuropathy across various formulations and patient subgroups.
Amazon has launched a GLP-1 weight management program that includes primary care and pharmacy in one place. View comments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results